United Therapeutics Corporation

United Therapeutics Corporation annual/quarterly gross profit history and growth rate from 2009 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.

• United Therapeutics Corporation gross profit for the quarter ending March 31, 2026 was 648.1 M, a 7.66% decrease year-over-year.
• United Therapeutics Corporation gross profit for the twelve months ending March 31, 2026 was 2.8 B, a 12.77% increase year-over-year.
• United Therapeutics Corporation annual gross profit for 2025 was 2.8 B, a 8.98% increase from 2024.
• United Therapeutics Corporation annual gross profit for 2024 was 2.6 B, a 24.04% increase from 2023.
• United Therapeutics Corporation annual gross profit for 2023 was 2.1 B, a 15.99% increase from 2022.
• United Therapeutics Corporation annual gross profit for 2022 was 1.8 B.